WallStreetZenWallStreetZen

NASDAQ: IMNM
Immunome Inc Earnings & Revenue

IMNM past revenue growth

How has IMNM's revenue growth performed historically?
Company
436.51%
Industry
89.98%
Market
18.88%
IMNM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IMNM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IMNM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IMNM earnings and revenue history

Current Revenue
$12.7M
Current Earnings
-$232.0M
Current Profit Margin
-1,829.4%

IMNM Return on Equity

Current Company
-220.5%
Current Industry
16.8%
Current Market
28.2%
IMNM's Return on Equity (-220.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IMNM announces earnings.

IMNM Return on Assets

Current Company
-153.9%
Current Industry
3.2%
IMNM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IMNM Return on Capital Employed

Current Company
-80.29%
Current Industry
-42.4%
IMNM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMNM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IMNM$12.68M-$231.19M-$232.03M+436.51%N/A
NUVB$0.00-$68.73M-$68.87MN/AN/A
ABVX$5.02M-$129.52M-$160.59M-38.54%N/A
AUPH$191.41M-$41.87M-$62.56M+233.64%N/A
ETNB$0.00-$157.09M-$165.03MN/AN/A

IMNM earnings dates

Next earnings date
Aug 7, 2024

Immunome Earnings & Revenue FAQ

What were IMNM's earnings last quarter?

On Invalid Date, Immunome (NASDAQ: IMNM) reported Q1 2024 earnings per share (EPS) of -$2.51, up 617.14% year over year. Total Immunome earnings for the quarter were -$129.49 million. In the same quarter last year, Immunome's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Immunome stock.

What was IMNM's earnings growth in the past year?

As of Q3 2024, Immunome's earnings has grown year over year. Immunome's earnings in the past year totalled -$232.03 million.

What is IMNM's earnings date?

Immunome's earnings date is Invalid Date. Add IMNM to your watchlist to be reminded of IMNM's next earnings announcement.

What was IMNM's revenue last quarter?

On Invalid Date, Immunome (NASDAQ: IMNM) reported Q1 2024 revenue of $1.03 million up 56.47% year over year. In the same quarter last year, Immunome's revenue was $2.36 million.

What was IMNM's revenue growth in the past year?

As of Q3 2024, Immunome's revenue has grown 436.51% year over year. This is 346.53 percentage points higher than the US Biotechnology industry revenue growth rate of 89.98%. Immunome's revenue in the past year totalled $12.68 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.